Abstract: A method, apparatus, and article of manufacture provide the ability to perform an operation on a multi-platform heterogeneous network. Path alias table (PAT) information necessary to create a PAT is obtained by a server. The PAT information includes alias(es) and location information necessary to locate a desired path for the alias(es). The server resolves the alias(es) using the PAT information by finding the desired path for the alias(es) within the file system of the server, building the PAT, and storing the PAT in a memory on the server. A request for an operation (comprising an alias) is received from a client. The PAT is then examined for the alias. Once found, the requested operation is performed using the desired path that corresponds to the alias in the PAT.
Type:
Grant
Filed:
October 29, 2002
Date of Patent:
April 22, 2008
Assignee:
International Business Machines Corporation
Abstract: Network configuration data is automatically written to data structures in a networked image data processing environment. The environment includes several image processing systems (101–108) in which each image processing system has direct access to a respective frame storage device (111–118). Each image processing system includes a local configuration file specifying details of its locally connected storage device in combination with a network configuration data structure. A network (121) allows each image processing system to indirectly access the frame storage devices of other connected image processing systems. An image processing system transmits details of system configuration data to other networked processing systems. Furthermore, configuration data received from other networked image processing systems is added to local configuration data.
Abstract: Growth hormones contain two receptor binding sites termed site 1 and site 2 with which they form ternary complexes with their receptors. In this scheme, site 1 on the hormone binds to one molecule of receptor and then site 2 binds to another molecule of receptor, thereby producing a 1:2 complex. Disclosed herein are growth hormone variants consisting of modifications to the native sequence in the region of site 1 or site 2, or alternatively a combination of modifications at both site 1 and site 2.